Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Kranjec C, Oftedal TF, Ovchinnikov KV, da Silva Duarte V, Hermansen S, Kaus-Drobek M, Sabała I, Porcellato D, Carlsen H, Kjos M(2025) An antibiotic-free antimicrobial combination of bacteriocins and a peptidoglycan hydrolase: in vitro and in vivo assessment of its efficacy Appl Environ Microbiol, e0243324(in press) DOI 10.1128/aem.02433-24, PubMed 40552825
Aga R, Søgaard AJ, Holvik K, Hagen TP, Idland G, Jeyananthan A, Melhuus KR, Rognerud M, Samuelsen SO, Meyer HE(2025) Effectiveness of a fall and fracture prevention pathway on hip fracture risk, need of permanent care and mortality: a controlled before-and-after study Age Ageing, 54(6) DOI 10.1093/ageing/afaf161, PubMed 40552367
Stokkebekk L, Kvande ME, Steindal SA(2025) Flight Nurses' Experiences With Interhospital Transportation of Critically Ill Patients J Clin Nurs(in press) DOI 10.1111/jocn.70014, PubMed 40548568